Your Location:
Home >
Browse articles >
Mechanisms of Oxyresveratrol in Inhibiting Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer via PI3K/Akt Signaling Pathway
Updated:2026-04-28
    • Mechanisms of Oxyresveratrol in Inhibiting Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer via PI3K/Akt Signaling Pathway

      Enhanced Publication
    • “Expert research has found that oxidized resveratrol can effectively inhibit the proliferation, migration, and invasion of non-small cell lung cancer cells by suppressing the PI3K/Akt signaling pathway and EMT process, providing new ideas for lung cancer treatment.”
    • HU Linling , JIANG Bo , QI Yu , ZOU Yilong , FAN Cunyu , FAN Yiling , YU Yihan , XU Bo
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 10, Pages: 46-57(2026)
    • DOI: 10.13422/j.cnki.syfjx.20251721     

      CLC:
    • Revised:2025-07-17 ,

      Accepted:23 July 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 15 ) Tabs( 17 )

  • References

  • Publication Info

  • Metrics

350

Views

273

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Graphene-mediated Far-infrared Therapy Enhances Anti-non-small Cell Lung Cancer Effects of Panax quinquefolium Saponins via cGAS/STING Signaling Pathway
Syndrome Differentiation and Treatment Strategies for NSCLC Immunotherapy from Perspective of Qi-Fire in Five Zang-Organs Based on Theory of Distance of Lung Fire
Mechanisms of Salvianolic Acid B in Inhibiting Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer by Downregulating PAICS Expression
Eupatilin Inhibits Proliferation, Invasion, and Metastasis of Non-small Cell Lung Cancer via EZH2/H3K27me3 Signaling Pathway
Effect and Mechanism of Liangyi Paste on Hepatic Lipid Deposition in Naturally Aged Mice with High-fat Diet via Cuproptosis/Oxidative Stress Pathway

Related Author

ZANG Huifang
GENG Zikai
GAO Yan
LIU Lu
WANG Yifei
ZHAO Bonian
LYU Jing
ZHANG Wenkang

Related Institution

Shandong Key Laboratory of Digital Traditional Chinese Medicine, Institute of Pharmacy, Shandong University of Traditional Chinese Medicine
Shandong Medical and Pharmaceutical University
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine
Hubei Shizhen Laboratory